ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0062

Tubular Stress Markers and Future Risk of Sepsis-Associated AKI

Session Information

Category: Acute Kidney Injury

  • 101 AKI: Epidemiology, Risk Factors, and Prevention

Authors

  • Lee, Adrian, University of California San Diego, La Jolla, California, United States
  • Katz, Ronit, University of Washington, Seattle, Washington, United States
  • Wong, Angela, University of California San Diego, La Jolla, California, United States
  • Guerrero, Felipe, Oakland University, Rochester, Michigan, United States
  • Vaingankar, Sucheta M., University of California San Diego, La Jolla, California, United States
  • Wettersten, Nicholas, VA San Diego Healthcare System, San Diego, California, United States
  • Judd, Suzanne E., University of Alabama at Birmingham Health System, Birmingham, Alabama, United States
  • Shlipak, Michael, San Francisco VA Health Care System, San Francisco, California, United States
  • Gutierrez, Orlando M., University of Alabama at Birmingham Health System, Birmingham, Alabama, United States
  • Bullen, Alexander L., VA San Diego Healthcare System, San Diego, California, United States
Background

Sepsis is one of the leading causes of death worldwide, particularly when it is complicated with acute kidney injury (AKI). Urinary tissue inhibitor of metalloproteinases-2 (TIMP-2) and insulin-like growth factor binding protein-7 (IGFBP7) are tubular stress markers shown to be early markers of AKI. We investigated the performance of both markers in identifying future risk of sepsis-associated AKI.

Methods

We performed a case-control study among participants who provided urine at the baseline visit in REGARDS, a population-based cohort study. Each septic AKI case by age, sex, race, and time from baseline to hospital admission 1:1 to a participant with sepsis who did not develop AKI (controls). Using conditional logistic regression, we evaluated the associations of TIMP-2, IGFBP7, and their product with the risk of septic AKI.

Results

Among 450 participants, mean age was 69 years, 44% were female, and 39% were Black participants. Median baseline eGFR among cases and controls was 73 and 82 mL/min/1.73m2, and median albuminuria was 19 vs. 9 mg/g, respectively. Mean follow-up was 4.3 years. IGFBP7 was associated with future risk of septic AKI after adjusting for baseline eGFR, albuminuria, and other risk factors (OR: 1.24, 95% CI [1.02, 1.52]). TIMP2 was not associated with septic AKI.

Conclusion

Among community participants, higher tubular stress is associated with risk of septic AKI independent of baseline eGFR and albuminuria.

Table. Association of biomarkers (per 2-fold higher) with risk of septic acute kidney injury
 Model*
 OR (95% CI)
Urine TIMP21.10 (0.92, 1.32)
Urine IGFBP71.24 (1.02, 1.52)
Urine [TIMP2][IGFBP7]1.11 (1.00, 1.25)

*Adjusted for urine creatinine, diabetes mellitus, systolic blood pressure, baseline eGFR, and urine albumin

Funding

  • NIDDK Support

Digital Object Identifier (DOI)